'Metformin' diaporamas de présentation

Managing the patient on insulin. A Practical Approach Neum Conference October 24, 2008 John A Geddes MD

829 views • 45 slides

Managing the patient on insulin. A Practical Approach Neum Conference October 24, 2008 John A Geddes MD

644 views • 45 slides

Hypertension and the |Metabolic Syndrome Karim Said Cardiology Department Cairo University

553 views • 44 slides

Insulin sensitizing agents use in pregnancy and as therapy in PCOS

Insulin sensitizing agents use in pregnancy and as therapy in PCOS. J. SERNA MD. PhD. IVI Madrid. TREAT WHAT?. Imparied. Treatment Options. Weight/Metabolic. Diet/lifestyle Metformin. Dysfunctional bleeding. Cyclic progesterone OCP. Infertility. Metformin Clomiphene Letrozole

580 views • 42 slides

CVD Workshop

CVD Workshop. SDPI CVD Risk Reduction Project Meeting #5 Denver, Colorado. Case Study. 62 year old woman presents for her scheduled intake visit for your CVD project She has been overweight most of her adult life and has a BMI of ~32 PMHx: HTN, diet controlled diabetes

480 views • 34 slides

Oral Hypoglycemic Agents in Pregnancy

Oral Hypoglycemic Agents in Pregnancy. Nafisa Dajani, M.D Department of Obstetrics and Gynecology Maternal Fetal Medicine Division University of Arkansas for Medical Sciences. History of Oral Hypoglycemic agents in obstetrics.

908 views • 32 slides

Journal Club

Journal Club. Aruna DP, Brendan ME, Nancy RC, Nader R, Paul MR Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes The LANCET Randomized Trial JAMA. 2009;302(11):1186-1194

406 views • 28 slides

Diabetes for the AKT

Diabetes for the AKT. September 2013. We reproduce below our feedback from AKT 16 which sadly continues to apply in AKT 17. Please re-read!

398 views • 26 slides

Case Presentation Managing treatment side effects in the correctional environment

Case Presentation Managing treatment side effects in the correctional environment. Stephen Tabet, MD, MPH University of Washington Division of Infectious Diseases Harborview Medical Center Northwest AETC. Background.

369 views • 23 slides

Oral Antidiabetic Agents Workshop

Oral Antidiabetic Agents Workshop. Hengameh Abdi, MD Endocrine Research Center Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran 1397.04.05 26 June 2018. Case presentation (1).

539 views • 20 slides

Management of Diabetes Mellitus

Management of Diabetes Mellitus. Dr Esther Tsang August 2011. Case 1. 50 year old lady presents to you with polyuria , polydipsia . You do a reflomet and it was 13.0mmol/L. Can you diagnose diabetes mellitus? How do you diagnose diabetes mellitus?.

462 views • 13 slides

Chapter 28 Jonathan G. Howlett , John C. MacFadyen

Canadian Diabete s Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure. Chapter 28 Jonathan G. Howlett , John C. MacFadyen. Diabetes in Heart Failure Checklist. 2013.

260 views • 13 slides

Introduction

Metformin-mode of action and clinical implications for diabetes and cancer Nat Rev Endocrinol. 2014 Mar;10(3):143-56. The biguanide metformin has been used for its glucose-lowering effect since 1957 in Europe and since 1995 in the USA

291 views • 12 slides

???? ?????? ?????? ???? 2

248 views • 8 slides

Using Drug Ontology to Bridge Clinical Trial Eligibility and Patient Record

Using Drug Ontology to Bridge Clinical Trial Eligibility and Patient Record. Helen Chen July 1, 2008. Drug Class Information in CT #8. monotherapy with metformin , insulin secretagogue , or alpha-glucosidase inhibitors and a low dose combination of all Long term insulin therapy

231 views • 6 slides

Metformin and its gastrointestinal problems: A review

Metformin is a biguanide class of drugs and has been recommended as first-line therapy for type 2 diabetes. It has a good safety profile, efficacy, comparatively reduced cost, and potential cardiovascular benefits. Metformin is an insulin-sensitizing agent, its bioavailability is 50%-60%. Generally, A1C levels are lowered by 1.5% points by metformin monotherapy. Treatment with metformin decreases fasting plasma glucose concentrations by 25% to 30% and decreases the production of glucose.

53 views • 5 slides

Metformin Weight Loss

Visit our site http://metforminsideeffectsblog.net/ for more information on Metformin Side Effects.Metformin is a range of medicine used in anti-diabetic procedure frequently referred so about because metformin metformin weight management. Metformin is additionally efficient in downsizing the actual livers ability to generate glucose.

419 views • 4 slides

4E-BP1

LKB1. 50. NIC-FF. NIC- LKB1 KD. p- AMPK ( T172 ). Metformin (hours). 50. 0 6 12 24 0 6 12 24. AMPK. 50. 37. S6. 37. p- S6 ( s240 /44). 4E-BP1. ?- Tubulin. 50. 20. Dupuy et al ., Additional file 6: Figure S6.

168 views • 1 slides

Introduction

131 views • 1 slides

Figure 4 Proposed actions of metformin in cancer

310 views • 1 slides